Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnostic Technology Performs Rapid Biofluid Analysis Using Single Droplet

By LabMedica International staff writers
Posted on 04 Dec 2025

Diagnosing disease typically requires milliliters of blood drawn at clinics, depending on needles, laboratory infrastructure, and trained personnel. More...

This process is often painful, resource-intensive, and inaccessible in many regions. Existing workflows overlook the rich diagnostic information embedded in the physical changes that biofluids undergo as they dry. Now, researchers have developed an automated imaging and machine-learning system that analyzes how tiny droplets of blood and other fluids dry to distinguish normal from abnormal samples.

The automated system, developed by researchers at the University of Tokyo (Tokyo, Japan), reduces reliance on traditional phlebotomy and expensive consumables by using microscopic imaging to observe biofluid droplets drying in real time. It eliminates the need for specialized diagnostic equipment by using a simple brightfield microscope with a 4x objective lens and a digital camera.

During the drying process, droplets undergo shape changes and internal pattern evolution driven by the movement of proteins, cells, and other biomolecules. These dynamic structural changes are captured frame by frame and then interpreted by a machine-learning algorithm trained to identify disease-associated abnormalities. Because the method relies on naturally occurring drying behaviors, it can also analyze saliva and urine without additional tools.

The research team demonstrated that time-evolving droplet images provide richer diagnostic information than solely examining the final dried pattern. Their machine-learning models accurately distinguished healthy from abnormal biofluid samples across multiple conditions, including diabetes, influenza, and malaria. In validation experiments, published in Science Advances, the researchers confirmed that the real-time drying profile carries a unique signature of the fluid’s composition.

This proof-of-concept work shows how drying-based imaging can serve as a rapid, low-cost diagnostic platform suitable for global deployment, especially in low-resource settings. By relying on tiny droplets instead of venous blood draws, the method enables broader screening, improves accessibility, and reduces medical waste. The researchers envision a portable device or mobile-based workflow that could extend laboratory-grade insights to populations without access to traditional testing. Future work aims to transform the system into a practical point-of-care health-screening tool.

“Such a tool could make health monitoring faster, more affordable and more accessible, especially in communities with limited access to laboratory testing. Ultimately, our goal is to bring laboratory-level insights to the point of care, enabling early detection and preventive health care for everyone,” said Amalesh Gope, co-author of the study.

Related Link
University of Tokyo


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
POC Immunoassay Analyzer
Procise DX
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.